On celebrex patent search, i got this on wiki
It is legally available in many jurisdictions as a generic under several brand names.
In the US, celecoxib was covered by three patents, two of which expired May 30, 2014, and one of which (US RE44048) was due to expire December 2, 2015.
On March 13, 2014, that patent was found to be invalid for double patenting.
Upon the patent expiry on May 30, 2014, FDA approved the first versions of celecoxib generic.
As per there recent concall, management was talking about launch of celebrex in December this year, [he was like we will be there on day 1 though he was not sure of date]
So he might be talking about this patent expiration.
US RE44048 patent
Issued: March 5, 2013
Assignee(s): G.D. Searle LLC
Patent expiration dates:
o June 2, 2015
TREATMENT OF PRIMARY DYSMENORRHEA, JUVENILE RHEUMATOID ARTHRITIS, ACUTE PAIN, ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS
o December 2, 2015
I think alembic will be targeting pediatric population.
I may be wrong at arriving this conclusion, seniors n fellow VPs ur views needed
Disc-invested from lower levels.